BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/24/2022 8:01:57 AM | Browse: 10 | Download: 11
Publication Name World Journal of Cardiology
Manuscript ID 78556
Country/Territory United States
Received
2022-07-03 06:35
Peer-Review Started
2022-07-03 06:39
To Make the First Decision
Return for Revision
2022-08-22 00:57
Revised
2022-09-17 06:58
Second Decision
2022-10-24 03:56
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2022-10-28 22:04
Articles in Press
2022-10-28 22:04
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2022-11-17 14:37
Publish the Manuscript Online
2022-11-24 08:01
ISSN 1949-8462 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Cardiac and Cardiovascular Systems
Manuscript Type Meta-Analysis
Article Title Potential for sodium-glucose cotransporter-2 inhibitors in the management of metabolic syndrome: A systematic review and meta-analysis
Manuscript Source Unsolicited Manuscript
All Author List Abdulbaril Olagunju, Naser Yamani, Dorothy Kenny, Martina Mookadam, Farouk Mookadam and Samuel Unzek
ORCID
Author(s) ORCID Number
Abdulbaril Olagunju http://orcid.org/0000-0001-9255-602X
Funding Agency and Grant Number
Corresponding Author Abdulbaril Olagunju, MD, Doctor, Internal medicine, Creighton University School of Medicine, 350 W Thomas Road, Phoenix, AZ 85013, United States. ab.dapoola@gmail.com
Key Words Metabolic syndrome; Sodium-glucose cotransporter 2 inhibitors; Dapagliflozin; Empagliflozin; Cardiovascular disease
Core Tip This meta-analysis of randomized, placebo-controlled trials aimed to evaluate the impact of dapagliglozin and empagliflozin on metabolic syndrome as defined by the National Cholesterol Education Program Adult Treatment Panel III. In doing so, it highlighted a statistically significant improvement in fasting plasma glucose, systolic blood pressure and waist circumference. The effect of dapagliflozin and empagliflozin on high-density lipoprotein cholesterol was similar to that of placebo. In addition to its primary aim, this study also highlighted an improvement in other cardiometabolic parameters including hemoglobin A1C, uric acid and body weight in patients that received dapagliflozin and empagliflozin.
Publish Date 2022-11-24 08:01
Citation Olagunju A, Yamani N, Kenny D, Mookadam M, Mookadam F, Unzek S. Potential for sodium-glucose cotransporter-2 inhibitors in the management of metabolic syndrome: A systematic review and meta-analysis. World J Cardiol 2022; 14(10): 599-616
URL https://www.wjgnet.com/1949-8462/full/v14/i11/599.htm
DOI https://dx.doi.org/10.4330/wjc.v14.i11.599
Full Article (PDF) WJC-14-599.pdf
Full Article (Word) WJC-14-599.docx
Manuscript File 78556-Manuscript-LM.docx
Answering Reviewers 78556-Answering reviewers.pdf
Audio Core Tip 78556-Audio core tip.m4a
Biostatistics Review Certificate 78556-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form 78556-Conflict-of-interest statement.pdf
Copyright License Agreement 78556-Copyright license agreement.pdf
Peer-review Report 78556-Peer-review(s).pdf
Scientific Misconduct Check 78556-Bing-Liu XF-2.png
Scientific Editor Work List 78556-Scientific editor work list.pdf